Platelet gel from cord blood: A novel tool for tissue engineering

Platelets

Volumn 21, Issue 7, 2010, Pages 549-554

  Parazzi, Valentina ^a   Lazzari, Lorenza ^a   Rebulla, Paolo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

cord blood; growth factors; peripheral blood; Platelet gel

Indexed keywords

FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; BLOOD; CONTROLLED STUDY; GEL; MAXILLOFACIAL SURGERY; ORTHOPEDIC SURGERY; PLATELET GEL; PRIORITY JOURNAL; SAFETY; SKIN SURGERY; THROMBOCYTE; TISSUE ENGINEERING; UMBILICAL CORD BLOOD;

FETAL BLOOD; GELS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PLATELET ACTIVATION; PLATELET COUNT; TISSUE ENGINEERING;

EID: 77958002485     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2010.514626     Document Type: Article

References (33)

1. Gluckman E. History of cord blood transplantation. Bone Marrow Transplant 2009;44:621-626.
2. McGuckin CP, Forraz N. Umbilical cord blood stem cells-an ethical source for regenerative medicine. Med Law 2008;27:147-165.
3. Brand A, Rebulla P, Engelfriet CP, Reesink HW, Beguin Y, Baudoux E, Kögler G, Ebrahimi M, Grazzini G, Costa AN, et al. Cord blood banking. Vox Sang 2008;95:335-348.
4. Rubinstein P. Cord blood banking for clinical transplantation. BMT 2009;44:635-642.
5. Garcia J. Allogeneic unrelated cord blood banking worldwide: An update. Transfus Apher Sci 2010;42:257-263.
6. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: Immunology and role in immuno-modulation and tissue regeneration. Cytotherapy 2009;11:377-391.
7. Jurk K, Kehrel BE. Platelets: Physiology and biochemistry. Semin Thromb Hemost 2005;31:381-392.
8. Driver VR, Hanft J, Fylling CP, Beriou JM. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 2006;52:68-74.
9. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: Involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 2002;13:529-535.
10. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4-15.
11. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 2005;84:434-439.
12. Carr ME, Carr SL, Tildon T, Fisher LM, Martin EJ. Batroxobin-induced clots exhibit delayed and reduced platelet contractile force in some patients with clotting factor deficiencies. J Thromb Haemost 2003;1:243-249.
13. Kubo T, Matsunaga T, Asai H, Kawamoto K, Kusakari J, Nomura Y, Oda M, Yanagita N, Niwa H, Uemura T, et al. Efficacy of defibrinogenation and steroid therapies on sudden deafness. Arch Otolaryngol Head Neck Surg 1988;114:649-652.
14. Gusev EI, Skvortsova VI, Suslina ZA, Avakian GN, Martynov Mlu, Temirbaeva SL, Tanashian MA, Kamchtnov PR, Stakhovskaia LV, Efremova NM. Batroxobin in patients with ischemic stroke in the carotid system (the multicenter study). Zh Nevrol Psikhiatr Im S S Korsakova 2006;106:31-34.
15. Wang HT, Jiang WL, Zhang YN, Sun ZF, Sun QF, Ma J. Multicentre clinical observation of anticoagulation and thrombolysis for the deep venous thrombosis. Zhonghua Yi Xue Za Zhi 2009;89:3181-3185.
16. Zeng Z, Xiao P, Chen J, Wei Y. Are batroxobin agents effective for perioperative hemorrhage in thoracic surgery? A systematic review of randomized controlled trials. Blood Coagul Fibrinolysis 2009;20:101-107.
17. Zhang L, Lu SH, Li L, Tao YG, Wan YL, Senga H, Yang R, Han ZC. Batroxobin mobilizes circulating endothelial progenitor cells in patients with deep vein thrombosis. Clin Appl Thromb Hemost 2009; Oct 13. [Epub ahead of print].
18. Sirchia G, Rebulla P, Mozzi F, Lecchi L, Lazzari L, Ratti I. A quality system for placental blood banking. Bone Marrow Transplant 1998;21:843.
19. Mazzucco L, Balbo V, Cattana E, Borzini P. Platelet-rich plasma and platelet gel preparation using Plateltex®. Vox Sang 2008;94:202-208.
20. Garcia A, Zitzmann N, Watson SP. Analyzing the platelet proteome. Semin Thromb Hemost 2004;30:485-489.
21. Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, Box HA, van Zundert A. Platelet-rich plasma and platelet gel: A review. J Extra Corpor Technol 2006;38:174-187.
22. Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001;107:229-237.
23. Mazzucco L, Balbo V, Cattana E, Guaschino R, Borzini P. Not every PRP-gel is born equal. Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet, RegenPRP-Kit, Plateltex and one manual procedure. Vox Sang 2009;97:110-118.
24. Kurane A, Vyavahare N. In vivo vascular tissue engineering: Influence of cytokine and implant location on tissue specific cellular recruitment. J Tissue Eng Regen Med 2009;3:280-289.
25. Tamama K, Kawasaki H, Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol Volume 2010 (2010), Article ID 795385.
26. Backen AC, Cummings J, Mitchell C, Jayson G, Ward TH, Dive C. 2009. 'Fit-for-purpose' validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use. J Immunol Methods 2009;342:106-114.
27. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-313.
28. Chen CW, Montelatici E, Crisan M, Corselli M, Huard J, Lazzari L, Péault B. Perivascular multi-lineage progenitor cells in human organs: Regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 2009;20:429-434.
29. Morigi M, Rota C, Montemurro T, Montelatici E, Lo Cicero V, Imberti B, Abbate M, Zoja C, Cassis P, Longaretti L, et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 2010;28:513-522.
30. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004;164:1935-1947.
31. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009;153:347-358.
32. Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Gillett NA, Amento EP. Rapid publication. TGF-beta1 induces bone closure of skull defects. J Bone Miner Res 1991;6:1257-1265.
33. Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, Zhao L, Nagy TR, Peng X, Hu J, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009;15:757-765.